Denise P Bury-Maynard

Title: Innovations in Cancer Pain Management by Denise P Bury-Maynard

Introduction

Denise P Bury-Maynard is a notable inventor based in Bridgewater, NJ (US). She has made significant contributions to the field of cancer treatment, particularly in pain management. Her innovative approach focuses on utilizing programmed death 1 (PD-1) inhibitors to alleviate cancer pain.

Latest Patents

Denise holds a patent for "Methods of treating cancer pain by administering a PD-1 inhibitor." This patent outlines methods for treating or inhibiting cancer pain in patients. It includes selecting patients with cancer and administering a therapeutically effective amount of a PD-1 inhibitor. The methods also aim to reduce the use of analgesics in patients undergoing background analgesic therapy prior to the administration of the PD-1 inhibitor. The disclosed methods can lead to tumor regression, pain reduction, and decreased reliance on analgesic therapy.

Career Highlights

Throughout her career, Denise has worked with prominent companies in the biotechnology sector, including Regeneron Pharmaceuticals, Inc. and Sanofi Biotechnology. Her work has been instrumental in advancing cancer treatment methodologies.

Collaborations

Denise has collaborated with esteemed colleagues such as Chieh-I Chen and Medha R Sasane. These partnerships have contributed to her innovative research and development in cancer pain management.

Conclusion

Denise P Bury-Maynard's contributions to cancer pain management through her innovative patent demonstrate her commitment to improving patient care. Her work continues to influence the field of oncology and pain management.